Source comparison
Kisspeptin Isoform Comparison
Kisspeptin-54 54 27–33 1.2–4.8 Historical reference; initial discovery studies 100% (baseline) 18–24 Kisspeptin-14 14 30–36 1.5–5.2 Intermediate-length comparisons 40–50% 20–28 Kisspeptin-10 10 35–42 1.0–5.0 Standard for mechanistic studies, in vivo dosing 25–
This comparison does not assign a generated winner or score.
- Kisspeptin-54
- 54
- 27–33
- 1.2–4.8
- Historical reference; initial discovery studies
- 100% (baseline)
- 18–24
- Kisspeptin-14
- 14
- 30–36
- 1.5–5.2
- Intermediate-length comparisons
- 40–50%
- 20–28
- Kisspeptin-10
- 10
- 35–42
- 1.0–5.0
- Standard for mechanistic studies, in vivo dosing
- 25–40%
- 24–36
- Kisspeptin-13
- 13
- 32–38
- 1.8–5.5
- Rarely used; structural variant studies
- 35–45%
- 22–30